| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | chloramphenicol (Eykappo®) |
| Formulation | eye drops |
| Reference number | 3586 |
| Indication | In adults and children for the treatment of acute bacterial conjunctivitis. Considerations should be given to official guidance on the appropriate use of antibacterial agents |
| Company | Aspire Pharma Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 08/09/2017 |